These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 36706843)
1. FD-1050@NPs-cRGD: A novel NIR-II fluorophore for triple-negative breast cancer imaging. Fan H; Wu W; Chen Z; Zhu Q; Sun X Bioorg Med Chem Lett; 2023 Feb; 82():129153. PubMed ID: 36706843 [TBL] [Abstract][Full Text] [Related]
2. Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer. Shemesh CS; Moshkelani D; Zhang H Pharm Res; 2015 May; 32(5):1604-14. PubMed ID: 25407543 [TBL] [Abstract][Full Text] [Related]
3. Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe. Zhang Y; Wang M; Liu W; Peng X Mol Imaging Biol; 2019 Oct; 21(5):835-841. PubMed ID: 30623283 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [ Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065 [TBL] [Abstract][Full Text] [Related]
5. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer. Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893 [TBL] [Abstract][Full Text] [Related]
7. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition. Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of tumor targeting rare-earth nanocrystals for real-time NIR-IIb fluorescence imaging-guided breast cancer precise surgery. Lou KL; Wang PY; Yang RQ; Gao YY; Tian HN; Dang YY; Li Y; Huang WH; Chen M; Liu XL; Zhang GJ Nanomedicine; 2022 Jul; 43():102555. PubMed ID: 35390525 [TBL] [Abstract][Full Text] [Related]
10. NIR diagnostic imaging of triple-negative breast cancer and its lymph node metastasis for high-efficiency hypoxia-activated multimodal therapy. Pan Y; Liu L; He Y; Ye L; Zhao X; Hu Z; Mou X; Cai Y J Nanobiotechnology; 2023 Sep; 21(1):312. PubMed ID: 37660121 [TBL] [Abstract][Full Text] [Related]
11. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer. Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636 [TBL] [Abstract][Full Text] [Related]
12. Near-infrared fluorescence imaging of both colorectal cancer and ureters using a low-dose integrin targeted probe. Verbeek FP; van der Vorst JR; Tummers QR; Boonstra MC; de Rooij KE; Löwik CW; Valentijn AR; van de Velde CJ; Choi HS; Frangioni JV; Vahrmeijer AL Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S528-37. PubMed ID: 24515567 [TBL] [Abstract][Full Text] [Related]
13. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen. Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651 [TBL] [Abstract][Full Text] [Related]
14. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer. Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194 [TBL] [Abstract][Full Text] [Related]
15. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer. Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941 [TBL] [Abstract][Full Text] [Related]
16. First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma. de Valk KS; Deken MM; Handgraaf HJM; Bhairosingh SS; Bijlstra OD; van Esdonk MJ; Terwisscha van Scheltinga AGT; Valentijn ARPM; March TL; Vuijk J; Peeters KCMJ; Holman FA; Hilling DE; Mieog JSD; Frangioni JV; Burggraaf J; Vahrmeijer AL Clin Cancer Res; 2020 Aug; 26(15):3990-3998. PubMed ID: 32345649 [TBL] [Abstract][Full Text] [Related]
17. A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors. Chatterjee S; Lesniak WG; Gabrielson M; Lisok A; Wharram B; Sysa-Shah P; Azad BB; Pomper MG; Nimmagadda S Oncotarget; 2016 Mar; 7(9):10215-27. PubMed ID: 26848870 [TBL] [Abstract][Full Text] [Related]
18. Multiplexed NIR-II Probes for Lymph Node-Invaded Cancer Detection and Imaging-Guided Surgery. Tian R; Ma H; Zhu S; Lau J; Ma R; Liu Y; Lin L; Chandra S; Wang S; Zhu X; Deng H; Niu G; Zhang M; Antaris AL; Hettie KS; Yang B; Liang Y; Chen X Adv Mater; 2020 Mar; 32(11):e1907365. PubMed ID: 32022975 [TBL] [Abstract][Full Text] [Related]
19. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer. Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068 [TBL] [Abstract][Full Text] [Related]
20. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma. Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]